THE EFFECT OF BODYWEIGHT ON RESPONSE TO INTRAVENOUS OR SUBCUTANEOUS TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引：2
|
作者：
Davies, R. [1 ]
Vivekanantham, A. [1 ]
Lunt, M. [1 ]
Watson, K. [1 ]
Hyrich, K. [1 ,2 ]
Bluett, J. [2 ,3 ]
机构：
[1] Univ Manchester, Ctr Epidemiol Versus Arthrit, Manchester, Lancs, England
[2] Manchester Acad Hlth Sci, Natl Inst Hlth Res Musculoskeletal Biomed Res Ctr, Manchester, Lancs, England
[3] Univ Manchester, Versus Arthrit Ctr Genet & Genom, Manchester, Lancs, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.4164
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0103
引用
收藏
页码：981 / 981
页数：1
相关论文
共 50 条
  • [1] Safety and tolerability of subcutaneous sarilumab and intravenous tocilizumab in patients with rheumatoid arthritis
    Emery, Paul
    Rondon, Juan
    Parrino, Janie
    Lin, Yong
    Pena-Rossi, Claudia
    van Hoogstraten, Hubert
    Graham, Neil M. H.
    Liu, Nancy
    Paccaly, Anne
    Wu, Richard
    Spindler, Alberto
    RHEUMATOLOGY, 2019, 58 (05) : 849 - 858
  • [2] Dose Modification of Subcutaneous Tocilizumab in Patients with Rheumatoid Arthritis Response
    Punekar, Rajeshwari
    Choi, Jeannie
    Boklage, Susan H.
    Iglesias-Rodriguez, Melitza
    Nola, Kamala
    AMERICAN HEALTH AND DRUG BENEFITS, 2020, 13 (02): : 73 - 73
  • [3] Evaluation of switching from intravenous to subcutaneous formulation of tocilizumab in patients with rheumatoid arthritis
    Iwamoto, Naoki
    Fukui, Shoichi
    Umeda, Masataka
    Nishino, Ayako
    Nakashima, Yoshikazu
    Suzuki, Takahisa
    Horai, Yoshiro
    Nonaka, Fumiaki
    Okada, Akitomo
    Koga, Tomohiro
    Kawashiri, Shin-ya
    Fujikawa, Keita
    Aramaki, Toshiyuki
    Ichinose, Kunihiro
    Hirai, Yasuko
    Tamai, Mami
    Nakamura, Hideki
    Terada, Kaoru
    Nakashima, Munetoshi
    Mizokami, Akinari
    Origuchi, Tomoki
    Eguchi, Katsumi
    Ueki, Yukitaka
    Kawakami, Atsushi
    MODERN RHEUMATOLOGY, 2016, 26 (05) : 662 - 666
  • [4] Doppler ultrasound impacts response to intravenous tocilizumab in rheumatoid arthritis patients
    Nicolette T. Morris
    Jenny Brook
    Ami Ben-Artzi
    William Martin
    Tanaz A. Kermani
    Lynette Avedikian-Tatosyan
    George Karpouzas
    Himakar Nagam
    Geraldine Navarro
    Soo Choi
    Mihaela B. Taylor
    David Elashoff
    Gurjit S. Kaeley
    Veena K. Ranganath
    Clinical Rheumatology, 2021, 40 : 5055 - 5065
  • [5] Doppler ultrasound impacts response to intravenous tocilizumab in rheumatoid arthritis patients
    Morris, Nicolette T.
    Brook, Jenny
    Ben-Artzi, Ami
    Martin, William
    Kermani, Tanaz A.
    Avedikian-Tatosyan, Lynette
    Karpouzas, George
    Nagam, Himakar
    Navarro, Geraldine
    Choi, Soo
    Taylor, Mihaela B.
    Elashoff, David
    Kaeley, Gurjit S.
    Ranganath, Veena K.
    CLINICAL RHEUMATOLOGY, 2021, 40 (12) : 5055 - 5065
  • [6] Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis
    Ogata, Atsushi
    Atsumi, Tatsuya
    Fukuda, Takaaki
    Hirabayashi, Yasuhiko
    Inaba, Masaaki
    Ishiguro, Naoki
    Kai, Motokazu
    Kawabata, Daisuke
    Kida, Daihei
    Kohsaka, Hitoshi
    Matsumura, Ryutaro
    Minota, Seiji
    Mukai, Masaya
    Sumida, Takayuki
    Takasugi, Kiyoshi
    Tamaki, Shigenori
    Takeuchi, Tsutomu
    Ueda, Atsuhisa
    Yamamoto, Kazuhiko
    Yamanaka, Hisashi
    Yoshifuji, Hajime
    Nomura, Akira
    ARTHRITIS CARE & RESEARCH, 2015, 67 (10) : 1354 - 1362
  • [7] Flare After Switching from Intravenous Tocilizumab to Subcutaneous Formulation in Patients with Rheumatoid Arthritis
    Ahn, Soo Min
    Oh, Ji Seon
    Heo, Hyun Mi
    Hong, Seokchan
    Lee, Chang-Keun
    Yoo, Bin
    Kim, Yong-Gil
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1728 - 1730
  • [8] Weekly subcutaneous injection of tocilizumab in patients with rheumatoid arthritis
    Ito, Satoshi
    MODERN RHEUMATOLOGY, 2018, 28 (01) : 17 - 19
  • [9] Dose Modification of Subcutaneous Tocilizumab in Patients with Rheumatoid Arthritis
    Best, Jennie H.
    Abbass, Ibrahim
    Tominna, Lenore
    Reiss, William
    AMERICAN HEALTH AND DRUG BENEFITS, 2020, 13 (02): : 72 - 73
  • [10] Utilisation of subcutaneous Tocilizumab in rheumatoid arthritis patients in Grampian
    Philobos, M.
    Davidson, A.
    Dospinescu, P.
    SCOTTISH MEDICAL JOURNAL, 2019, 64 (03) : NP39 - NP39
12345